A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data 1 1 Financial disclosure: This study was sponsored by Novartis Ophthalmics, Inc., the distributor of unoprostone isopropyl (Rescula®) in Europe and the U.S. Dr. Nordmann is a consultant for Novartis Ophthalmics, Inc. The investigators received compensation for conducting the study, but have no proprietary or stock interest in Novartis Ophthalmics, Inc.
Titel:
A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data 1 1 Financial disclosure: This study was sponsored by Novartis Ophthalmics, Inc., the distributor of unoprostone isopropyl (Rescula®) in Europe and the U.S. Dr. Nordmann is a consultant for Novartis Ophthalmics, Inc. The investigators received compensation for conducting the study, but have no proprietary or stock interest in Novartis Ophthalmics, Inc.
Auteur:
Nordmann, Jean-Philippe Mertz, Beat Yannoulis, Natalia C Schwenninger, Christine Kapik, Barry Shams, Naveed